Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-SC007576
Host Cell : HEK293 (CHO and other cell types are also available) Size : >1x106 frozen cells/vial
| Cat. No. | CSC-SC007576 |
| Description | Using Creative Biogene's proprietary lentiviral vectors, we subclone the target gene into lentivector, generate the lentivirus particles, sequentially infect the cell line HEK293 (other cell types are also available according to your requirements), and select the clones constantly expressing target gene at high level. |
| Target Gene | IL22 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | HEK293 (CHO and other cell types are also available) |
| Host Cell Species | Species varies |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Disease research |
| Size | 2 × 10^6 cells / vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry Ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | IL22 interleukin 22 [ Homo sapiens ] |
| Gene Symbol | IL22 |
| Synonyms | IL22; interleukin 22; interleukin-22; IL 10 related T cell derived inducible factor; IL 21; IL 22; IL D110; IL TIF; ILTIF; MGC79382; MGC79384; TIFa; TIFIL 23; zcyto18; cytokine Zcyto18; IL-10-related T-cell-derived inducible factor; IL-10-related T-cell-derived-inducible factor; IL-21; IL-22; IL-TIF; IL-D110; TIFIL-23; |
| GeneID | 50616 |
| Uni ProtID | Q9GZX6 |
| mRNA Refseq | BC069308 |
| Chromosome Location | 12q15 |
| Function | cytokine activity; interleukin-22 receptor binding; |
| Pathway | Cytokine-cytokine receptor interaction, organism-specific biosystem; Cytokine-cytokine receptor interaction, conserved biosystem; Jak-STAT signaling pathway, organism-specific biosystem; Jak-STAT signaling pathway, conserved biosystem; |
| MIM | 605330 |
Inflammation is considered a hallmark of cancer and is closely associated with gastric cancer. Interleukin-22 (IL-22), a member of the IL-10 family, plays a crucial role in inflammatory diseases and tumors. In this study, researchers investigated the effect of IL-22 on the proliferation of cultured gastric cancer cells (AGS cells) and the underlying molecular mechanisms. Cell Counting Kit-8 (CCK-8) assays using AGS cells transfected with an IL-22 plasmid demonstrated that IL-22 promoted cell viability; conversely, knockdown of IL-22 expression using short hairpin RNA (shRNA) significantly reduced AGS cell viability. Western blotting results revealed that IL-22 inhibited the activation of the mitogen-activated protein kinase (MAPK) signaling pathway. Furthermore, transfection with IL-22-shRNA enhanced MAPK pathway activation, as evidenced by the upregulation of ERK and JNK phosphorylation levels. Collectively, these findings indicate that IL-22 regulates gastric cancer cell viability via the JNK signaling pathway, suggesting that targeting IL-22 may represent a potential therapeutic strategy for gastric cancer.
Here, the viability of AGS cells was assessed using the CCK-8 assay at various time points following transfection. As shown in Figure 1, IL-22-overexpressing AGS cells showed significantly increased viability compared with the control group. Conversely, IL-22 knockdown significantly reduced the viability of AGS cells compared to the control shRNA group.
Figure 1. IL-22 increases the viability of AGS cells. (Dong H, et al., 2020)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.